Providing Diabetes and Endocrine Services in Nevada

  • info Please use messages for non-urgent communications only. If this is an emergency, please call 911.

Nitesh D. Kuhadiya, MD, MPH, is the Founder & Director of DECON(Diabetes & Endocrine Center of Nevada). He is a widely accomplished endocrinologist and a key thought leader in the area of Diabetes.

Dr Kuhadiya has vast clinical experience in providing cutting edge Diabetes & Endocrine care during his tenure as Clinical Assistant Professor at University at Buffalo and as Endocrinology Program Director at Renown Health,Reno,Nevada.

Dr Kuhadiya has published over three dozen papers in elite and high impact factor journals, including the Journal of Clinical Endocrinology and Metabolism(JCEM), Diabetes, Obesity and Metabolism(DOM), European Journal of Endocrinology(EJE), Diabetes Care, American Journal of Physiology-Endocrinology and Metabolism, Clinical Endocrinology, Endocrine Practice and AACE Case Reports Journal.He has also spearheaded important proof of concept studies exploring the role of GLP-1RA and SGLT-2 inhibitors in type 1 diabetes (T1D).

Dr. Kuhadiya is a member of the Endocrine Society, the American Association of Clinical Endocrinologists(AACE) &American Diabetes Association(ADA).He is often an invited speaker at American Diabetes Association Scientific Sessions, the National Endocrine Society Annual Meeting, and the American Association of Clinical Endocrinology Annual Meetings and industry conferences. Dr. Kuhadiya has also received the American DiabetesAssociation’s Young Investigator Travel Grant Award, the Leona M. and Harry B. Helmsley Charitable Trust Award for outstanding research in Type 1 Diabetes (two-time recipient), the Endocrine Society’s Early Investigators Workshop Award, and the American Geriatrics Society Best Poster Award.

He also received the award of Junior Faculty for outstanding research from University at Buffalo during his tenure as clinical assistant professor.

  • arrow_forwardEndocrine
  • arrow_forwardEndocrinology
  • arrow_forwardEndocrinologist
  • arrow_forwardDiabetes
  • arrow_forwardWellness Check Up
  • arrow_forwardVisits
  • arrow_forwardImmunizations
  • arrow_forwardSick Visits
  • arrow_forwardHospital Visits
  • arrow_forwardNewborn Consultation
  • arrow_forwardSports Visits
  • arrow_forwardNutrition Information


Board Certification - Internal Medicine
American Board of Internal Medicine

Board Certification - Endrocrinology, Diabetes and Metabolism
American Board of Internal Medicine and Subspecialty


Nevada State Board of Medical Examiners

New York State Medical License

Diabetes & Endocrine Center Of Nevada - DECON

Providing Diabetes and Endocrine Services in Nevada

Address: 5444 Reno Corporate Drive, Reno, NV 89511

Phone: 775-507-2555

Fax: 775-284-9082

Office Hours
Monday 8:00 AM - 5:00 PM
Tuesday 8:00 AM - 5:00 PM
Wednesday 8:00 AM - 5:00 PM
Thursday 8:00 AM - 5:00 PM
Friday 8:00 AM - 5:00 PM
Saturday Closed
Sunday Closed

Connect on Social Media

Insurance Providers Accepted

Medicare as well as most major national and local carriers

Patient Forms

Please print and fill out these forms so we can expedite your first visit:

Meet Our Doctors

Nitesh D. Kuhadiya, MD, MPH
Dr. Nitesh D. Kuhadiya MD, MPH

Nitesh D. Kuhadiya, MD, MPH, is the Founder & Director of DECON - Diabetes & Endocrine Center of Nevada. He is a widely accomplished endocrinologist and a key thought leader in the area of Diabetes. Dr Kuhadiya has vast clinical experience in providing cutting edge Diabetes & Endocrine care during his tenure as Clinical Assistant Professor at University at Buffalo and as Endocrinology Program Director at Renown Health, Reno, Nevada.

Ben Prohaska
Ben Prohaska PA-C, BC-ADM

Ben Prohaska, PA-C, BC-ADM, DFAAPA has been working in medicine here in Reno, Nevada since 2005 and spent his first 10 years of clinical practice working in Internal Medicine with a focus in diabetes. He has practiced Adult Endocrinology with a focus in diabetes management since 2016. Ben received his Board Certification in Advanced Diabetes Management in June of 2016. Ben is also a Board member of the Nevada Diabetes Association and volunteers as a medical staff member at Diabetes Kids Camp.


  • Rao, A.D., Kuhadiya, N., Reynolds, K., and Fonseca, V.A. 2008. Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies. Diabetes Care 31:1672-1678.
  • Fonseca, V.A., Smith, H., Kuhadiya, N., Leger, S.M., Yau, C.L., Reynolds, K., Shi, L., McDuffie, R.H., Thethi, T., and John-Kalarickal, J. 2009. Impact of a natural disaster on diabetes: exacerbation of disparities and long-term consequences. Diabetes Care 32:1632-1638. 
  • Kuhadiya, N.D., Malik, R., Bellini, N.J., Patterson, J.L., Traina, A., Makdissi, A., and Dandona, P. 2013. Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitus. Endocr Pract 19:963- 967.
  • Dandona, P., Ghanim, H., Green, K., Sia, C.L., Abuaysheh, S., Kuhadiya, N., Batra, M., Dhindsa, S., and Chaudhuri, A. 2013. Insulin infusion suppresses while glucose infusion induces Toll -like receptors and highmobility group-B1 protein expression in mononuclear cells of type 1 diabetes patients. Am J Physiol Endocrinol Metab 304:E810-818.
  • Ghanim, H., Green, K., Abuaysheh, S., Batra, M., Kuhadiya, N.D., Patel, R., Makdissi, A., Dhindsa, S., Chaudhuri, A., and Dandona, P. 2015. Suppressive effect of insulin on the gene expression and plasma concentrations of mediators of asthmatic inflammation. J Diabetes Res 2015:202406.
  • Thethi, T., Katalenich, B., Nagireddy, P., Chabbra, P., Kuhadiya, N., and Fonseca, V. 2015. Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta -Analysis. Endocr Pract:1-57.
  • Dhindsa S, Ghanim H, Batra M, Kuhadiya ND, Abuaysheh S, Sandhu S, Green K, Makdissi A, Hejna J, ChaudhuriA, Punyanitya M, Dandona P. Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes. Diabetes Care 2016;39:1–10
  • Kuhadiya ND , Dhindsa.S, Ghanim H, Mehta A, Makdissi A, Batra M, Sandhu S, Hejna J,Green K, Bellini N, Yang M, Chaudhuri A ,Yang M, Dandona P. 2014. Liraglutide As Additional Treatement To Insulin In Patients With Type 1 Diabetes Mellitus : A Randomized Placebo-Controlled Clinical Trial of 12 Weeks. Diabetes Care 2016 Jun;39(6):1027-35.
  • Kuhadiya ND, Ghanim H, Mehta A, Garg M, Khan S, Hejna J, Torre B, Makdissi A, Chaudhuri A, Batra M. Dapagliflozin as Additional Treatment to Liraglutide and Insulin In Patients With Type 1 Diabetes. Journal of Clinical Endocrinology & Metabolism .2016 Sep;101(9):3506 -15
  • Dhindsa S, Ghanim H, Batra M, Kuhadiya ND, Abuaysheh S, Green K, Makdissi A, Chaudhuri A. and Dandona,P. (2016). Effect of Testosterone on Hepcidin, Ferroportin, Ferritin and Iron Binding Capacity in Patients with Hypogonadotropic Hypogonadism and Type 2 Diabetes. Clin Endocrinol. Accepted Author Manuscript. doi:10.1111/cen.13130


patient portal

Our Patient Portal gives you secure online access to your health information

Patient Portal is a secure, convenient, and easy-to-use website that gives you round-the-clock access to your health information. View labs, medications, and immunization records. Get reminders. Exchange messages with your doctor. Stay informed and take charge of your health!

Here’s what you can do with our portal
  • checkView lab results
  • checkSend & receive messages securely
  • checkAccess health records
  • checkBook appointments online
  • checkGet statements and receipts online
  • checkView doctors’ notes
Patient Portal Login

Need help logging in? Call us at 775-507-2555

Online health access on your smartphone

Access your health record with the healowTM smartphone app. Along with the features you get with our Patient Portal, the healow app can manage multiple accounts (all family members), set medication and appointment reminders, and use trackers to help manage health. The healow app is a secure and convenient way to manage what’s important and puts YOU in control of your health.

healow is available free on the Apple app store and Google Play store.

Download free healow smartphone app
App StorePlay Store

To learn more about healow, click here

healow app

Set up the healow smartphone app in four easy steps!

Download the healow app from App Store (iPhone) or Google Play (Android Phone).

Search for our practice by entering this unique code on the healow app - IHJCCD.

Enter your portal username and password.

Set up your PIN to securely access your health record.

Use this unique code to search our practice on the healow app

Practice Unique Code